A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital

Background: Adverse drug reactions (ADRs) pose a major health concern worldwide, especially in paediatric oncology where unlicensed or off-label drugs are commonly used. These reactions can have a significant impact on the quality of treatment and the safety of patients, particularly in vulnerable p...

Full description

Saved in:
Bibliographic Details
Main Authors: Nancy Khajuria, Nikhil Menia, Seema Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jpbs.jpbs_653_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544110590132224
author Nancy Khajuria
Nikhil Menia
Seema Gupta
author_facet Nancy Khajuria
Nikhil Menia
Seema Gupta
author_sort Nancy Khajuria
collection DOAJ
description Background: Adverse drug reactions (ADRs) pose a major health concern worldwide, especially in paediatric oncology where unlicensed or off-label drugs are commonly used. These reactions can have a significant impact on the quality of treatment and the safety of patients, particularly in vulnerable paediatric populations. Aims and Objectives: The purpose of this study is to examine the occurrence and characteristics of chemotherapy-related adverse drug reactions in children with cancer at a teaching hospital specialising in advanced medical care. Furthermore, it aims to evaluate the intensity and cause of these reactions by utilising the NARANJO probability scale and other assessment instruments. Materials and Methods: During a three-month period, we conducted a study at SMGS Jammu, in collaboration with GMC Jammu’s Pharmacology Department. The study was observational in nature and followed a prospective approach. The study included 45 children undergoing chemotherapy, utilising both spontaneous and intensive monitoring systems to report and analyse adverse drug reactions. We conducted statistical analysis using Chi-Square and Fisher Exact tests. Results: Among the 45 patients included in the study, 20 individuals (44.44%) experienced adverse drug reactions (ADRs), with a higher prevalence observed among female patients (55%). Fever and vomiting were the most common adverse drug reactions observed, with most of them being classified as moderate in severity based on the Modified Hartwig and Siegel Scale. Commonly linked medications to adverse drug reactions include Methotrexate, Vincristine, L-asparaginase, and Cytarabine. There was no significant statistical link discovered between different categories of anticancer drugs and adverse drug reactions. Conclusion: this study highlights the prevalence of adverse drug reactions (ADRs) in children undergoing chemotherapy, particularly in those receiving treatment for acute lymphoblastic leukaemia. The findings emphasise the significant impact of ADRs on these patients. It is of utmost importance to closely monitor and manage adverse drug reactions (ADRs) in paediatric oncology, emphasising the importance of implementing improved drug safety measures.
format Article
id doaj-art-0c632f032de64accae45f2cee0e65fa3
institution Kabale University
issn 0976-4879
0975-7406
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj-art-0c632f032de64accae45f2cee0e65fa32025-01-12T14:08:57ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0976-48790975-74062024-12-0116Suppl 4S3167S316910.4103/jpbs.jpbs_653_24A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching HospitalNancy KhajuriaNikhil MeniaSeema GuptaBackground: Adverse drug reactions (ADRs) pose a major health concern worldwide, especially in paediatric oncology where unlicensed or off-label drugs are commonly used. These reactions can have a significant impact on the quality of treatment and the safety of patients, particularly in vulnerable paediatric populations. Aims and Objectives: The purpose of this study is to examine the occurrence and characteristics of chemotherapy-related adverse drug reactions in children with cancer at a teaching hospital specialising in advanced medical care. Furthermore, it aims to evaluate the intensity and cause of these reactions by utilising the NARANJO probability scale and other assessment instruments. Materials and Methods: During a three-month period, we conducted a study at SMGS Jammu, in collaboration with GMC Jammu’s Pharmacology Department. The study was observational in nature and followed a prospective approach. The study included 45 children undergoing chemotherapy, utilising both spontaneous and intensive monitoring systems to report and analyse adverse drug reactions. We conducted statistical analysis using Chi-Square and Fisher Exact tests. Results: Among the 45 patients included in the study, 20 individuals (44.44%) experienced adverse drug reactions (ADRs), with a higher prevalence observed among female patients (55%). Fever and vomiting were the most common adverse drug reactions observed, with most of them being classified as moderate in severity based on the Modified Hartwig and Siegel Scale. Commonly linked medications to adverse drug reactions include Methotrexate, Vincristine, L-asparaginase, and Cytarabine. There was no significant statistical link discovered between different categories of anticancer drugs and adverse drug reactions. Conclusion: this study highlights the prevalence of adverse drug reactions (ADRs) in children undergoing chemotherapy, particularly in those receiving treatment for acute lymphoblastic leukaemia. The findings emphasise the significant impact of ADRs on these patients. It is of utmost importance to closely monitor and manage adverse drug reactions (ADRs) in paediatric oncology, emphasising the importance of implementing improved drug safety measures.https://journals.lww.com/10.4103/jpbs.jpbs_653_24adrcancerchemotherapynaranjopaediatric patients
spellingShingle Nancy Khajuria
Nikhil Menia
Seema Gupta
A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
Journal of Pharmacy and Bioallied Sciences
adr
cancer
chemotherapy
naranjo
paediatric patients
title A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
title_full A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
title_fullStr A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
title_full_unstemmed A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
title_short A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
title_sort prospective observational study on adverse drug reactions in hospitalized pediatric cancer patients in a tertiary care teaching hospital
topic adr
cancer
chemotherapy
naranjo
paediatric patients
url https://journals.lww.com/10.4103/jpbs.jpbs_653_24
work_keys_str_mv AT nancykhajuria aprospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital
AT nikhilmenia aprospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital
AT seemagupta aprospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital
AT nancykhajuria prospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital
AT nikhilmenia prospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital
AT seemagupta prospectiveobservationalstudyonadversedrugreactionsinhospitalizedpediatriccancerpatientsinatertiarycareteachinghospital